Month: August 2021

TORONTO and CHICAGO, Aug. 11, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the commencement of functional animal studies to determine effect of a psilocybin-based regimen on locomotor activity as well as anxiety and depression. Results from the anxiety and depression study are expected by early Q4 2021. “The locomotor study was designed to determine whether selected combinations of doses of the test product had any effects on locomotor activity and how pronounced this effect might be. Preliminary results, just released,...

–On track to report topline data from a clinical study of KB295 in patients with mild-to-moderate ulcerative colitis by end of third quarter– –Kaleido and the COPD Foundation to collaborate on the development of KB109 in patients with COPD; plan to initiate Phase 2 clinical study in first quarter 2022– –Additional data from an observational clinical study of KB109 in patients with mild-to-moderate COVID-19 expected by end of third quarter– LEXINGTON, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today reported financial results for the second quarter ended June 30, 2021. “We have made considerable progress...

PIPESTONE DEVELOPMENT MAPPIPESTONE DEVELOPMENT MAPCALGARY, Alberta, Aug. 11, 2021 (GLOBE NEWSWIRE) — (PIPE – TSX) — Pipestone Energy Corp. (“Pipestone” or the “Company”) is pleased to report its Q2 2021 financial and operational results, as well as provide an update on its operations. During Q2 2021, Pipestone delivered record quarterly production and cash flow, underpinned by the continued efficient execution of its organic development program. The Company remains on track to generate free cash flow beginning in Q4 2021, with forecast annual free cash flow of $95 million in 2022 and $190 million in 2023 (US$65 WTI | C$2.50 AECO). SECOND QUARTER 2021 CORPORATE HIGHLIGHTS:Record average quarterly production of 23,336 boe/d (31% condensate, 46% total liquids), an 8% quarterly increase over Q1 2021 and a 39%...

TORONTO, Aug. 11, 2021 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce the commencement of the maiden diamond drilling program and the completion of a structural Geological interpretation at its Betty Property, contiguous to and 15km northeast of Western Copper and Gold Corporation’s Casino deposit (14.5 Moz gold & 7.1 Blbs copper of Measured & Indicated and 6.6 Moz gold and 3.3 Blb copper of Inferred), and 40km east of Newmont Corporation’s Coffee Gold deposit (2.17 Moz Indicated & 0.50 Moz Inferred gold). This is the second diamond drilling campaign of the company’s fully funded 2021 exploration program on its district scale 420,000 hectare land package, representing over 40% of the emerging White Gold District in Yukon, Canada,...

Figure 1Section through Clouds East with recent intercepts and Grade Shell (≥0.4g/t Au) from April 2021 Mineral Resource Estimate (results shown in blue annotations are new assays not previously reported).Figure 2Subcrop Geology with Twin Hills Drill Collars and Highlights of Recent DrillingFigure 3Section through Bulge mineralization including Grade Shell (≥0.4g/t Au) from April 2021 Mineral Resource Estimate (results shown in blue annotation are new assays not previously reported).Further Expansion and Infill Assay Results From Bulge and Twin Hills CentralTwin Hills Gold Project, Namibia HighlightsClouds East high-grade shoot extended down to 200m below surface; grade and width of mineralization improves with depth and indicates the potential to substantially increase the size of the...

KING OF PRUSSIA, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced financial results for its second quarter ended June 30, 2021. “Our performance reflects strong demand across all our segments and product lines this quarter, as global businesses, governments and communities work to emerge from this past year stronger than ever,” said David DeStefano, Vertex President and Chief Executive Officer. “We continue to execute on our strategy to accelerate global commerce, with investments in go-to-market expansion and our cloud platform driving revenues from our cloud business up 59.5% year-over-year in the second quarter.” Second Quarter 2021 Financial ResultsTotal revenues of $104.9 million, up 15.0% year-over-year. Software...

Philadelphia, PA, Aug. 11, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (the Company or “VSBLTY”), a leading software provider of security and retail analytics technology, today announced that it has entered into a license agreement (the “License Agreement”) with RADAR USA, Inc. (“RADAR USA”) to develop a security product offering and associated services for sale in the United States and Canada. RADAR USA was formed in 2021 as a collaboration between VSBLTY and RADAR APP in Mexico, where the security network deployment has reached 10,000 cameras. Jay Hutton, VSBLTY founder & CEO, said, “The licensing agreement with RADAR USA is a major step toward bringing effective and affordable security technology into U.S. and Canadian neighborhoods and making them safer. The collaborative...

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website: https://ponstreatment.com, created to serve as a resource for U.S.-based patients and physicians. The website is designed to provide both audiences with information on the Company’s PoNS Treatment and enable them to connect with Helius to learn more information, ask questions and receive future updates. “We are pleased to expand our online resources for U.S.-based patients and physicians as we prepare to commercialize our PoNS technology during the first quarter of 2022,” said Dane Andreeff, President and Chief Executive Officer of Helius. “Building on this progress, we look forward...

CALGARY, Alberta, Aug. 11, 2021 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today announced that Bill Tempany, Interim CEO, and Alana Forbes, CFO, will present virtually at the Q3 Investor Summit on Tuesday, August 17, 2021, at 2:45 pm ET (12:45 pm MT). Management of FLYHT will also be available for one-on-one meetings with investors throughout the two-day event.DATE: Tuesday, August 17, 2021TIME: 2:45 pm ET (12:45 pm MT)LINK: https://zoom.us/webinar/register/WN_rJQwpKq4SQ2jQyoJxh6z3gAn archived webcast of the presentation will be made available at www.investorsummitgroup.com and in the Investors section of the FLYHT website at www.flyht.com/investors. For additional information or to schedule a meeting with FLYHT management, please register for the conference...

Received minutes from Type C meeting with the FDA confirming alignment on path toward resubmission of FUROSCIX® NDA; no additional clinical data or device modifications required at this time; on track for resubmission in Q4 Announced positive top-line results from the FREEDOM-HF study demonstrating that average 30-day heart failure-related costs were reduced by $17,753 per study subject in the FUROSCIX arm compared to historically matched comparators Ended Q2 with cash, cash equivalents, restricted cash and investments of $90.2 million, sufficient to fund operations, as currently planned, into 2023; lowered 2021 net loss guidance to $30.0 to $34.0 million BURLINGTON, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have...